Horizon Capital Invests in Viseven, Leading Global Pharma and Life Sciences MarTech Provider
Posted:
Horizon Capital, a U.S. private equity firm investing primarily in fast-growing tech and export-oriented businesses in Ukraine, announced an investment in Viseven, a leading global marketing tech provider servicing the pharma and life sciences industry. This transaction marks the third investment from its latest fund, Horizon Capital Growth Fund IV (HCGF IV), which reached $328 million at its most recent closing held in December 2023.
Joel Torres and Joe Maniski-Luke, speakers at GIANT Healht's The National ICS Innovation Congress in December 2024, are inviting you to the upcoming webinar: Enhancing your accreditation programme with Tendable.
When: Thu, 20 Feb
Time: 13:00 - 14:00 CET
Place: Online
Register here.
Hampshire Hospitals NHS Foundation Trust has launched Lung Cancer Screening in the fight against lung cancer.
The screening involves an initial phone conversation to check eligibility followed by a further telephone appointment with a healthcare professional which will focus on…